Updates and news related to prostate cancer:
LuPSMA offers a new option for men with castration-resistant PSMA-positive metastatic cancer.
Detection may be more accurately than mpMRI
Men with low-risk prostate cancer on active surveillance report fewer problems with sexual function than those on other treatments.
Molecular imaging tools have the potential to transform how we diagnose and treat men with prostate cancer.
Study will likely change the standard of care
A discussion on the challenges associated with the use of MRI to diagnose prostate cancer including insurance coverage and patient discomfort
Early management of side effects has been shown to help patients live longer, better lives.
This therapy may yield a significant reduction in all-cause mortality in high-risk prostate cancer vs salvage
Blood test shows accuracy for early cancer detection
Metformin plus standard of care (SOC) prolonged castration-resistant prostate cancer-free survival compared with SOC alone in patients with low-tumor-volume metastatic hormone-sensitive prostate cancer and high-risk locally advanced disease.